Terms: = Prostate cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Staging
94 results:
1. Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer.
Scheipner L; Baudo A; Jannello LMI; Siech C; de Angelis M; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Carmignani L; De Cobelli O; Mischinger J; Ahyai S; Karakiewicz PI
World J Urol; 2024 Apr; 42(1):269. PubMed ID: 38679642
[TBL] [Abstract] [Full Text] [Related]
2. Assessment of the accuracy of biparametric MRI/TRUS fusion-guided biopsy for index tumor evaluation using postoperative pathology specimens.
Shimizu R; Morizane S; Yamamoto A; Yamane H; Nishikawa R; Kimura Y; Yamaguchi N; Hikita K; Honda M; Takenaka A
BMC Urol; 2024 Apr; 24(1):79. PubMed ID: 38575912
[TBL] [Abstract] [Full Text] [Related]
3. prostate cancer and elective nodal radiation therapy for cN0 and pN0-a never ending story? : Recommendations from the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO).
Koerber SA; Höcht S; Aebersold D; Albrecht C; Boehmer D; Ganswindt U; Schmidt-Hegemann NS; Hölscher T; Mueller AC; Niehoff P; Peeken JC; Pinkawa M; Polat B; Spohn SKB; Wolf F; Zamboglou C; Zips D; Wiegel T
Strahlenther Onkol; 2024 Mar; 200(3):181-187. PubMed ID: 38273135
[TBL] [Abstract] [Full Text] [Related]
4. Combination of [
Kim J; Lee S; Kim D; Kim HJ; Oh KT; Kim SJ; Choi YD; Giesel FL; Kopka K; Hoepping A; Lee M; Yun M
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1763-1772. PubMed ID: 38200396
[TBL] [Abstract] [Full Text] [Related]
5. Methylation status of various gene loci in localized prostate cancer: Novel biomarkers for diagnostics and biochemical recurrence.
Eismann L; von Walter P; Jung A; Chaloupka M; Rodler S; Westhofen T; Buchner A; Stief CG; Stadler T; Schlenker B
Urol Oncol; 2023 Jul; 41(7):325.e1-325.e8. PubMed ID: 37179150
[TBL] [Abstract] [Full Text] [Related]
6. Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features.
Guerra A; Alves FC; Maes K; Joniau S; Cassis J; Maio R; Cravo M; Mouriño H
Cancer Imaging; 2022 Dec; 22(1):74. PubMed ID: 36550525
[TBL] [Abstract] [Full Text] [Related]
7. Safely omitting bone isotope scans in a cohort of grade group 2 prostate cancer.
Mustaffa A; Emara S
Prostate; 2023 Jan; 83(1):128-131. PubMed ID: 36176053
[TBL] [Abstract] [Full Text] [Related]
8.
Pizzuto DA; Triumbari EKA; Morland D; Boldrini L; Gatta R; Treglia G; Bientinesi R; De Summa M; De Risi M; Caldarella C; Scarciglia E; Totaro A; Annunziata S
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012384
[TBL] [Abstract] [Full Text] [Related]
9. A Web-Based Prediction Model for cancer-Specific Survival of Elderly Patients Undergoing Surgery With prostate cancer: A Population-Based Study.
Zhang Z; Zhanghuang C; Wang J; Mi T; Liu J; Tian X; Jin L; He D
Front Public Health; 2022; 10():935521. PubMed ID: 35903379
[TBL] [Abstract] [Full Text] [Related]
10. Cribriform Morphology in Gleason Score 3+4 Moderate-Risk prostate cancer: Is it Risk Factor for Biochemical Recurrence?
Yahşi S; Ceylan C; Kizilkan Y; Şenel S; Ceviz K
Arch Esp Urol; 2022 May; 75(4):325-329. PubMed ID: 35818912
[TBL] [Abstract] [Full Text] [Related]
11. Contemporary Pathological Stage Distribution After Radical prostatectomy in North American High-Risk prostate cancer Patients.
Chierigo F; Borghesi M; Würnschimmel C; Flammia RS; Sorce G; Hoeh B; Hohenhorst L; Tian Z; Saad F; Tilki D; Gallucci M; Briganti A; Montorsi F; Chun FKH; Shariat SF; Mantica G; Suardi N; Terrone C; Karakiewicz PI
Clin Genitourin Cancer; 2022 Oct; 20(5):e380-e389. PubMed ID: 35618597
[TBL] [Abstract] [Full Text] [Related]
12. Trends in Incidence of Metastatic prostate cancer in the US.
Desai MM; Cacciamani GE; Gill K; Zhang J; Liu L; Abreu A; Gill IS
JAMA Netw Open; 2022 Mar; 5(3):e222246. PubMed ID: 35285916
[TBL] [Abstract] [Full Text] [Related]
13. Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis.
Corrao G; Marvaso G; Zaffaroni M; Volpe S; Augugliaro M; Fodor CI; Zerini D; Vingiani A; Mistretta FA; Luzzago S; Alessi S; Pricolo P; Musi G; De Cobelli O; Renne G; Manzoni M; Petralia G; Orecchia R; Jereczek-Fossa BA
Neoplasma; 2022 Mar; 69(2):404-411. PubMed ID: 35014537
[TBL] [Abstract] [Full Text] [Related]
14. Incremental Impact of [
Szigeti F; Schweighofer-Zwink G; Meissnitzer M; Hauser-Kronberger C; Hitzl W; Kunit T; Forstner R; Pirich C; Beheshti M
Mol Imaging Biol; 2022 Feb; 24(1):50-59. PubMed ID: 34519966
[TBL] [Abstract] [Full Text] [Related]
15. The added value of PSMA PET/MR radiomics for prostate cancer staging.
Solari EL; Gafita A; Schachoff S; Bogdanović B; Villagrán Asiares A; Amiel T; Hui W; Rauscher I; Visvikis D; Maurer T; Schwamborn K; Mustafa M; Weber W; Navab N; Eiber M; Hatt M; Nekolla SG
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):527-538. PubMed ID: 34255130
[TBL] [Abstract] [Full Text] [Related]
16. Utility of radiomic zones for risk classification and clinical outcome predictions using supervised machine learning during simultaneous
Tu SJ; Tran VT; Teo JM; Chong WC; Tseng JR
Med Phys; 2021 Sep; 48(9):5192-5201. PubMed ID: 34214211
[TBL] [Abstract] [Full Text] [Related]
17. Clinical parameters and nomograms for predicting lymph node metastasis detected with
Onal C; Ozyigit G; Oymak E; Guler OC; Hurmuz P; Tilki B; Reyhan M; Tuncel M; Akyol F
Prostate; 2021 Jul; 81(10):648-656. PubMed ID: 33949694
[TBL] [Abstract] [Full Text] [Related]
18. Correlations of
Topuz ÖV; Aksu A; Erinç SR; Tamam MÖ
Hell J Nucl Med; 2021; 24(1):60-65. PubMed ID: 33866340
[TBL] [Abstract] [Full Text] [Related]
19. prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary prostate cancer.
Chu CE; Alshalalfa M; Sjöström M; Zhao SG; Liu Y; Chou J; Herlemann A; Mahal B; Kishan AU; Spratt DE; Cooperberg M; Small E; Wong A; Porten S; Hope TA; Ross AE; Davicioni E; Nguyen P; Karnes RJ; Carroll PR; Schaeffer E; Feng FY
Eur Urol; 2021 Jun; 79(6):717-721. PubMed ID: 33840559
[No Abstract] [Full Text] [Related]
20. MRI/US fusion prostate biopsy in men on active surveillance: Our experience.
Lacetera V; Antezza A; Papaveri A; Cappa E; Cervelli B; Gabrielloni G; Montesi M; Morcellini R; Parri G; Recanatini E; Beatrici V
Arch Ital Urol Androl; 2021 Mar; 93(1):88-91. PubMed ID: 33754618
[TBL] [Abstract] [Full Text] [Related]
[Next]
